Demand for over-the-counter pain medication will increase through 2035, with non-steroidal anti-inflammatory drugs at 45.2% share of the drug class segment in 2025. Oral administration holds 82.5% share of the administration segment. The market is expected to reach USD 24.7 billion in 2025 and USD 36.5 billion by 2035.